Support core for programs reducing unhealthy drinking in people with HIV
METHODS AND ANALYSIS CORE
This project tries to help people with HIV who drink too much by using a counseling program called CETA to reduce drinking and improve HIV health.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11173877 on NIH RePORTER |
What this research studies
You would join HIV clinics in either Zambia or Alabama where researchers are running two linked trials comparing a counseling approach called CETA to standard care. People are randomly assigned, and study staff follow drinking patterns, mental health, and HIV outcomes like viral suppression over time. The Methods and Analysis Core organizes the trials’ randomization, measurement tools, data management, and statistical analyses, including tests of how alcohol reduction may lead to better HIV results. The team will also study costs and practical issues in delivering CETA in front-line HIV clinics.
Who could benefit from this research
Good fit: Adults living with HIV who report unhealthy alcohol use and receive care at participating clinics in Zambia or Alabama are ideal candidates.
Not a fit: People without HIV, those who do not drink alcohol, or those not treated at participating clinics would not directly benefit from this project.
Why it matters
Potential benefit: If successful, this could help people with HIV drink less, improve mental health, and achieve better HIV treatment outcomes.
How similar studies have performed: Transdiagnostic counseling like CETA has helped reduce mental health and substance problems in prior global trials, but its direct impact on alcohol use and HIV outcomes across Zambia and the U.S. is still being tested.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Bosomprah, Samuel — University of Alabama at Birmingham
- Study coordinator: Bosomprah, Samuel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.